Insys Bribed Docs To Write Opioid Scripts, DOJ, 6 States Say

Law360 (May 15, 2018, 6:08 PM EDT) -- The U.S. Department of Justice and six states have joined whistleblower litigation, unsealed Monday, accusing Insys Therapeutics of bribing doctors to prescribe the fentanyl painkiller Subsys off-label, purportedly costing the federal government tens of millions of dollars.

The U.S. complaint, filed April 13 under seal, says Insys created fake speaking events to funnel money to doctors and nurse practitioners as a quid pro quo for their writing Subsys prescriptions.

“Many of these events have been mere pretexts for paying thousands of dollars in sham speaking fees,”...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.